Ranitidine hydrochloride induces significant autophagy in cells
This study demonstrates that ranitidine hydrochloride, but not tiapride, induces significant autophagy characterized by increased LC3-II expression, decreased HSP70 expression, and polycystic vesicle formation in A549 cells and mouse bone marrow cells.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine your body as a bustling city, and inside every building (cell), there's a complex waste management and recycling system. Sometimes, cells need to clean up their own trash or repair damaged parts. They do this by wrapping old or broken pieces in tiny, bubble-like containers called vesicles. Think of these vesicles as little delivery trucks or recycling bins that the cell uses to move things around or get rid of waste. One specific type of cleanup crew is called autophagy (literally "self-eating"), where the cell swallows its own junk to stay healthy. Scientists are always curious about how medicines might accidentally mess with this delicate recycling system. If a common drug causes the cell's recycling trucks to go haywire, it could explain why some medicines have weird side effects, like making people feel tired or hurting organs. This is the playground where our story takes place: a look at how two very common, inexpensive drugs might be accidentally turning on the cell's "clean-up mode" too hard.
In this study, researchers decided to test two familiar drugs: Ranitidine hydrochloride (often used to calm an upset stomach) and tiapride hydrochloride (used to help with certain mental health conditions). They wanted to see what happened when they exposed two types of cells to these drugs: A549 cells (a type of lung cell often used in labs) and mouse bone marrow cells. They treated these cells with different amounts of the drugs for 24 hours and then looked at them under powerful microscopes.
The results were quite dramatic. When the cells were exposed to higher doses of Ranitidine (specifically 4.78 mmol/L) or Tiapride (specifically 2.73 mmol/L), they didn't just look a little different; they started filling up with huge, multi-layered bubbles. The researchers called these "polycystic vesicular changes." It was as if the cell's recycling trucks had gotten stuck in a traffic jam, piling up inside the cell. However, when they used lower doses (like 2.39 mmol/L for Ranitidine), the cells looked normal, with no extra bubbles.
To see if this was a permanent damage or just a temporary reaction, the scientists played a game of "switcheroo." After the cells had been sitting in the drug for 24 hours, they washed the drug away and gave the cells fresh food (new culture medium). If the cells were allowed to recover in this fresh environment, the crazy bubble-filled look disappeared, and the cells started growing normally again. But, if the scientists left the drugs in the dish and let the cells sit in them for another 24 hours, the bubbles stayed, and the cells eventually started to look like they were dying (similar to a process called apoptosis). This suggests the effect is reversible if the drug is removed quickly.
The team didn't just look at the bubbles; they wanted to know why they were happening. They ran a test called a Western blot to check for specific proteins that act like "on/off switches" for the cell's recycling system. They found that the drug Ranitidine turned up the volume on a protein called LC3-II (a marker that says "we are recycling!") and turned down a protein called HSP70 (which usually helps protect the cell). This chemical signature confirmed that Ranitidine was indeed triggering a significant amount of autophagy. They also checked if the drugs were causing fat to build up (using a red dye called Oil Red O), but found nothing, ruling out fat storage as the cause of the bubbles.
So, what's the big takeaway? The paper suggests that these two cheap, common drugs can cause cells to fill up with recycling bubbles and trigger a strong self-cleaning response. While the study doesn't prove that this causes side effects in humans, it offers a fascinating clue: maybe the tiredness or organ issues some people feel from these drugs are linked to their cells getting stuck in overdrive, trying to clean up too much. The researchers hope that by understanding how these drugs turn on the cell's recycling system, we can learn more about how autophagy works and how to keep our cellular cities running smoothly.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.